Back to Search Start Over

In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity.

Authors :
Anderson, Richard J.
Guru, Siradanahalli
Weeratna, Risini
Makinen, Shawn
Falconer, Derek J.
Sheppard, Neil C.
Lang, Susanne
Chang, Bingsheng
Goenaga, Anne-Laure
Green, Bruce A.
Merson, James R.
Gracheck, Stephen J.
Eyles, Jim E.
Source :
Vaccine. Dec2016, Vol. 34 Issue 50, p6292-6300. 9p.
Publication Year :
2016

Abstract

We evaluated 52 different E. coli expressed pneumococcal proteins as immunogens in a BALB/c mouse model of S. pneumoniae lung infection. Proteins were selected based on genetic conservation across disease-causing serotypes and bioinformatic prediction of antibody binding to the target antigen. Seven proteins induced protective responses, in terms of reduced lung burdens of the serotype 3 pneumococci. Three of the protective proteins were histidine triad protein family members (PhtB, PhtD and PhtE). Four other proteins, all bearing LPXTG linkage domains, also had activity in this model (PrtA, NanA, PavB and Eng). PrtA, NanA and Eng were also protective in a CBA/N mouse model of lethal pneumococcal infection. Despite data inferring widespread genomic conservation, flow-cytometer based antisera binding studies confirmed variable levels of antigen expression across a panel of pneumococcal serotypes. Finally, BALB/c mice were immunized and intranasally challenged with a viulent serotype 8 strain, to help understand the breadth of protection. Those mouse studies reaffirmed the effectiveness of the histidine triad protein grouping and a single LPXTG protein, PrtA. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0264410X
Volume :
34
Issue :
50
Database :
Academic Search Index
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
119773516
Full Text :
https://doi.org/10.1016/j.vaccine.2016.10.061